Central nervous system regeneration is driven by microglia necroptosis and repopulation
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index; 13 of the 17 sources its claims cite were checked for support.
Abstract
Failed regeneration of CNS myelin contributes to clinical decline in neuroinflammatory and neurodegenerative diseases, for which there is an unmet therapeutic need. Here we reveal that efficient remyelination requires death of proinflammatory microglia followed by repopulation to a pro-regenerative state. We propose that impaired microglia death and/or repopulation may underpin dysregulated microglia activation in neurological diseases, and we reveal therapeutic targets to promote white matter regeneration.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
9 Valid · 1 Not valid · 0 Not checked · 39 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“These disorders (e.g. multiple sclerosis, ALS, spinal cord injury) are associated with chronic activation of resident immune cells, microglia2–4.”
§ Central nervous system regeneration is driven by microglia necroptosis and repopulation > Abstract
What the sources say
- Supportedcites [2] Frakes A Neuron 2014 81 1009 1023 24607225 PMC3978641 source
The Introduction describes microglial activation as a hallmark of ALS in patients and rodent models. The Discussion adds that inflammatory microglial markers increase with disease progression, supporting the ALS portion of the multi-citation sentence. (LLM, conf=0.90)
- Partly supportedcites [3] Miron V Nature Neuroscience 2013 16 1211 1218 23872599 PMC3977045 sourceExperimental — accuracy not yet measured
The Results section (“Increased M2 densities during efficient remyelination”; page unavailable) reports elevated microglia/macrophage and M1-cell densities in MS lesions, including chronic lesions, supporting the MS portion of the claim. The Discussion mentions studies of neuronal injury, and the references list ALS and injured-spinal-cord studies, but this paper does not establish chronic microglial activation in ALS or spinal cord injury. (LLM, conf=0.86)
- Supportedcites [4] Kigerl K J Neurosci 2009 29 13435 13444 19864556 PMC2788152 source
The Introduction reports that microglia become pro-inflammatory M1 macrophages after spinal cord injury and that M1 cells remain at lesion sites for weeks. The Discussion describes macrophages persisting at spinal cord lesions indefinitely. With multiple citations attached to the sentence, this paper supports the spinal-cord-injury example; it does not establish the multiple-sclerosis or ALS examples. (LLM, conf=0.87)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This did not result from directly inhibiting oligodendrocyte or neuronal necroptosis11,12, as only ~3% of oligodendrocyte lineage cells (Olig2+) or neurons (NeuN+) were RIPK3+ post-LPC in explants (Supplementary Fig. 8A-D).”
§ Central nervous system regeneration is driven by microglia necroptosis and repopulation > Abstract
What the sources say
- Partly supportedcites [11] Ofengeim D Cell Reports 2015 10 1836 1849 25801023 PMC4494996 sourceExperimental — accuracy not yet measured
The Results section, “Activation of necroptosis in oligodendrocytes by TNFα” (page unavailable), reports that a RIPK1 inhibitor protected oligodendrocytes from TNFα-induced necroptotic death. This supports the background relevance of oligodendrocyte necroptosis, but the source does not report the ~3% RIPK3+ finding in post-LPC explants or establish that necrostatin-1 did not directly inhibit oligodendrocyte or neuronal necroptosis there. (LLM, conf=0.83)
- Not checked — no full text of the sourcecites [12] Caccamo, A. et al. Nat. Neurosci. 20, 1236–1246 (2017). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Resolution of pro-inflammatory microglia activation (iNOS+ TNFα+ CCL2+) via a transition to a pro-regenerative microglia state (Arg-1+ CD206+ IGF-1+) initiates remyelination3.”
§ Central nervous system regeneration is driven by microglia necroptosis and repopulation > Abstract
What the sources say
- Partly supportedcites [3] Miron V Nature Neuroscience 2013 16 1211 1218 23872599 PMC3977045 sourceExperimental — accuracy not yet measured
The Results section, “An M1 to M2 switch at the initiation of remyelination” (page unavailable), reports an M1-to-M2 shift as remyelination begins and identifies iNOS and TNFα as M1 markers and Arg-1, mannose receptor, and IGF-1 as M2 markers. The Discussion says M2 microglia/macrophages drive oligodendrocyte differentiation. The copy does not identify CCL2 as a marker of the pro-inflammatory state, and it describes the switch as occurring at the initiation of remyelination rather than establishing that the switch itself initiates it. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In vivo lesions showed increased co-localization of IBA-1 with Nestin from 3 dpl to 7 dpl, which was reduced by 10 dpl when the transition in microglia activation has taken place (Fig. 3A-C).”
§ Central nervous system regeneration is driven by microglia necroptosis and repopulation > Abstract
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Flow cytometric analysis of microglia (CD11b+CD45lo) revealed an increase in death (Annexin-V+ 7-AAD+) at 7 dpl (Fig. 1J, K; gating strategy Supplementary Fig. 3A; Supplementary Fig. 3C).”
§ Central nervous system regeneration is driven by microglia necroptosis and repopulation > Abstract
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
16 more claims
Create a free account to see all 49 claims and to verify the 1 reference still open.
- It may state two separate claims as one. 22
- Probably not a substantial claim. 13
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Proliferation of microglia depends on CSF1R signaling through PU.1 and C/EBPα (Gomez-Nicola et al., 2013), and we now show that microglial apoptosis is also modulated by PU.1 (Fig. 3), which in vivo leads to regeneration of white matter after death of pro-inflammatory microglia following demyelination (Lloyd et al., 2019).”
From Alzheimer's-associated PU.1 expression levels regulate microglial inflammatory response (2021) · cites this paper as Lloyd et al., 2019
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Central nervous system regeneration is driven by microglia necroptosis and repopulation > Methods > Immunofluorescent staining of explant cultures
“rabbit anti-RIPK3 (Novus Biologicals, NBP1-77299, 1:100)”
§ Central nervous system regeneration is driven by microglia necroptosis and repopulation > Methods > Human Tissue
“rat anti-RIPK3 (Novus Biologicals, NBP1-77299, 1:100)”
Citations
Cites
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T. K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.018 · Cited by 5,493
Krasemann, S., Madore, C., Cialic, R., Baufeld, C., Calcagno, N., El Fatimy, R., Beckers, L., O’Loughlin, E., Xu, Y., Fanek, Z., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.08.008 · Cited by 2,979
Hammond, T. R., Dufort, C., Dissing-Olesen, L., Giera, S., Young, A., Wysoker, A., Walker, A. J., Segel, M., Nemesh, J., Saunders, A., et al. (2018) · doi:10.1101/406140 · Cited by 2,225
Kigerl, K. A., Gensel, J. C., Ankeny, D. P., Alexander, J. K., Donnelly, D. J., & Popovich, P. G. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3257-09.2009 · Cited by 2,130
Elmore, M. R. P., Najafi, A. R., Koike, M. A., Dagher, N. N., Spangenberg, E. E., Rice, R. A., Kitazawa, M., Matusow, B., Nguyen, H., West, B. L., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.02.040 · Cited by 1,968
M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination
Miron, V. E., Boyd, A., Zhao, J.-W., Yuen, T. J., Ruckh, J. M., Shadrach, J. L., van Wijngaarden, P., Wagers, A. J., Williams, A., Franklin, R. J. M., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3469 · Cited by 1,777
Self-citationRegenerating CNS myelin — from mechanisms to experimental medicines
Franklin, R. J. M., & ffrench-Constant, C. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.136 · Cited by 647
Microglia Induce Motor Neuron Death via the Classical NF-κB Pathway in Amyotrophic Lateral Sclerosis
Frakes, A. E., Ferraiuolo, L., Haidet-Phillips, A. M., Schmelzer, L., Braun, L., Miranda, C. J., Ladner, K. J., Bevan, A. K., Foust, K. D., Godbout, J. P., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.01.013 · Cited by 638
Bruttger, J., Karram, K., Wörtge, S., Regen, T., Marini, F., Hoppmann, N., Klein, M., Blank, T., Yona, S., Wolf, Y., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.06.012 · Cited by 634
Huang, Y., Xu, Z., Xiong, S., Sun, F., Qin, G., Hu, G., Wang, J., Zhao, L., Liang, Y.-X., Wu, T., et al. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0090-8 · Cited by 595
Cited by
Microglia Biology: One Century of Evolving Concepts
Prinz, M., Jung, S., & Priller, J. (2019) · Cell · doi:10.1016/j.cell.2019.08.053 · Cited by 1,525
Self-citationMicroglia in Neuroinflammation and Neurodegeneration: From Understanding to Therapy
Muzio, L., Viotti, A., & Martino, G. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.742065 · Cited by 581
“However, soon after the death of these cells, repopulating microglia have regenerative functions and support remyelination (Lloyd et al., 2019).”
BackgroundMicroglia regulate central nervous system myelin growth and integrity
McNamara, N. B., Munro, D. A. D., Bestard-Cuche, N., Uyeda, A., Bogie, J. F. J., Hoffmann, A., Holloway, R. K., Molina-Gonzalez, I., Askew, K. E., Mitchell, S., et al. (2023) · Nature · doi:10.1038/s41586-022-05534-y · Cited by 507
Self-citationWhite matter aging drives microglial diversity
Safaiyan, S., Besson-Girard, S., Kaya, T., Cantuti-Castelvetri, L., Liu, L., Ji, H., Schifferer, M., Gouna, G., Usifo, F., Kannaiyan, N., et al. (2021) · Neuron · doi:10.1016/j.neuron.2021.01.027 · Cited by 477
Microglia and astrocyte dysfunction in parkinson's disease
Kam, T.-I., Hinkle, J. T., Dawson, T. M., & Dawson, V. L. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105028 · Cited by 389
Metadata
- Authors
- Lloyd, A. F., Davies, C. L., Holloway, R. K., Labrak, Y., Ireland, G., Carradori, D., Dillenburg, A., Borger, E., Soong, D., Richardson, J. C., Kuhlmann, T., Williams, A., Pollard, J. W., des Rieux, A., Priller, J., & Miron, V. E.
- Affiliations
- MRC Centre for Reproductive Health (GB)
- UCLouvain (BE)
- MRC Centre for Regenerative Medicine (GB)
- GlaxoSmithKline (United Kingdom) (GB)
- University Hospital Münster (DE)
- Charité – Universitätsmedizin Berlin (DE)
- ORCID
- Venue
- Nature Neuroscience
- Published
- 2019-06-10
- Volume
- 22
- Issue
- 7
- Pages
- 1046-1052
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- PMC
- PMC6597360
- OpenAlex
- W2948490412
- Semantic Scholar
- 3180579cbd8fd06fe04e477cc1af9e49adf485b2
- Cited by
- 340
- References
- 20
- Citations by year
- 2026: 24 · 2025: 37 · 2024: 48 · 2023: 58 · 2022: 54 · 2021: 54 · 2020: 48 · 2019: 16
- FWCI
- 18.27
- Type
- journal article
- Language
- en
- Open access
- green
- pmc.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion, other-oa)
- DIAL (Catholic University of Leuven) (submittedVersion, other-oa)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Funders
- GlaxoSmithKline
- Wellcome Trust (101067, 101067/Z/13/Z)
- Multiple Sclerosis Society (MR/M020827/1)
- Imperial College London
- Deutsche Forschungsgemeinschaft (TR‐128, SFB TR‐128, SFB-TR128-B7)
- International Foundation for Research in Paraplegia
- Fonds De La Recherche Scientifique - FNRS
- Fondation Charcot
- Directorate for Biological Sciences
- Medical Research Council (MR/M020827/1, MR/P016022/1, MR/N022556/1, MC_PC_16031, MR/N02256/1)
- Biotechnology and Biological Sciences Research Council (BB/M502777/1)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- microglia, necroptosis, microglial repopulation, remyelination, microglial activation, neuroinflammation, neurodegenerative diseases, therapeutic target
- MeSH terms
- Animals, Corpus Callosum, Demyelinating Diseases, Female, Humans, Inflammation, Lysophosphatidylcholines, Male, Mice, Inbred C57BL, Multiple Sclerosis, Necrosis, Nerve Regeneration, Phagocytosis, Rats, Sprague-Dawley, Sequence Analysis, RNA, Microglia, Gene Expression Profiling, Mice, Rats, Nestin, White Matter
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-16, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-16 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Central nervous system regeneration is driven by microglia necroptosis and repopulation. https://app.cochat.ai/papers/10.1038/s41593-019-0418-z
- The paper
- Lloyd, A. F., Davies, C. L., Holloway, R. K., Labrak, Y., Ireland, G., Carradori, D., Dillenburg, A., Borger, E., Soong, D., Richardson, J. C., Kuhlmann, T., Williams, A., Pollard, J. W., des Rieux, A., Priller, J., & Miron, V. E. (2019). Central nervous system regeneration is driven by microglia necroptosis and repopulation. Nature Neuroscience. https://doi.org/10.1038/s41593-019-0418-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.